Bayview Pharmacy is pleased to present our Progesterone 250 mg Slow Release Capsules, a specialized formulation designed to address a range of health conditions. Progesterone is a crucial hormone in the female reproductive system, and our unique formulation ensures a gradual and consistent release of this hormone over an extended period.

This formulation is crafted with Methocel E4M, a type of controlled-release polymer. This innovative technology allows for the gradual release of the encapsulated medication or active ingredient over an extended period, providing sustained therapeutic effects. This slow-release mechanism reduces the need for frequent dosing and enhances patient compliance, particularly for medications that require a controlled and prolonged release profile.

Our Progesterone 250 mg Slow Release Capsules are used to treat a variety of conditions, including endometriosis, uterine fibroids, and abnormal uterine bleeding. They can also be used to manage menopausal symptoms, such as hot flashes and night sweats.

These capsules are taken orally, typically once a day, and should be consumed with food to ensure optimal absorption. Patients should be aware that this formulation may take several weeks to reach its full effect, and it may take several months to experience the full benefits.

It's important for prescribers to note that Progesterone 250 mg Slow Release Capsules may interact with other medications, and patients should be closely monitored for any adverse effects. Potential side effects of this formulation may include nausea, headache, and breast tenderness.

If you have any queries about our Progesterone 250 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. We are committed to helping you find the most effective treatment option for your specific needs.

Progesterone 250 mg Slow Release Capsules, formulated with Methocel E4M, a controlled-release polymer, are designed to gradually release the active ingredient over an extended period. This formulation offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile. However, these capsules may interact with other medications, supplements, or herbal products, potentially altering their effectiveness or increasing the risk of side effects.

Patients should inform their healthcare provider of all medications, supplements, and herbal products they are taking before starting Progesterone 250 mg Slow Release Capsules. Potential interactions include anticoagulants such as warfarin, which may increase the risk of bleeding; anti-seizure medications like phenytoin, which may decrease the effectiveness of the anti-seizure medication; and antibiotics such as rifampin, which may decrease the effectiveness of the antibiotic.

Other potential interactions include antifungal medications like ketoconazole, which may decrease the effectiveness of the antifungal medication; anti-anxiety medications such as diazepam, which may increase the risk of sedation; and anti-depressant medications like fluoxetine, which may increase the risk of serotonin syndrome. Anti-hypertensive medications such as lisinopril may increase the risk of hypotension, while diuretics like furosemide may increase the risk of dehydration. Hormones like insulin may also interact with Progesterone 250 mg Slow Release Capsules, increasing the risk of hypoglycemia.

Patients taking any of these medications should be monitored closely for signs of potential side effects. If you have any questions about the interactions of Progesterone 250 mg Slow Release Capsules, please consult with your healthcare provider.

Progesterone 250 mg Slow Release Capsules are a hormone replacement therapy designed to treat a variety of conditions, including menopause, premenstrual syndrome, and endometriosis. This formulation is uniquely designed with Methocel E4M, a controlled-release polymer, which allows for a gradual and sustained release of the encapsulated progesterone over an extended period of time. This slow release mechanism offers consistent hormone replacement, reduced dosing frequency, and improved patient compliance, particularly beneficial for those who experience side effects from other forms of progesterone, such as oral tablets.

When taken as directed, Progesterone 250 mg Slow Release Capsules can help to alleviate symptoms associated with menopause, such as hot flashes, night sweats, and vaginal dryness. It can also contribute to reducing the risk of osteoporosis and endometrial cancer. Furthermore, it can help to mitigate the symptoms of premenstrual syndrome, such as mood swings, irritability, and bloating.

Progesterone 250 mg Slow Release Capsules should be taken as directed by your healthcare provider. Consistency is key in ensuring the effectiveness of this medication, hence it is recommended to take the capsules at the same time each day, preferably in the evening. To ensure proper absorption, it is also advised to take the capsules with food.

If you have any questions or concerns about Progesterone 250 mg Slow Release Capsules, please do not hesitate to reach out to us at Bayview Pharmacy. We are committed to helping you find the best treatment option tailored to your individual needs.

Progesterone 250 mg Slow Release Capsules are a compounded formulation designed to offer sustained therapeutic effects over an extended period of time. This is achieved through the use of Methocel E4M, a type of controlled-release polymer that gradually releases the encapsulated medication or active ingredient. This formulation is designed to reduce dosing frequency and improve patient compliance, particularly for medications requiring a controlled and prolonged release profile.

These capsules may be used to treat a variety of conditions. They can be used in the management of preterm labor and recurrent miscarriages, as well as in the treatment of postpartum depression. In cases of infertility due to luteal phase defect, Progesterone 250 mg Slow Release Capsules may be used to induce ovulation. For postmenopausal women receiving estrogen replacement therapy, these capsules can be used to prevent endometrial hyperplasia. Certain types of breast cancer in postmenopausal women may also be treated with this formulation of progesterone.

It is crucial to note that progesterone should not be used to treat any condition in premenopausal women unless specifically prescribed by a healthcare provider. If you have any questions about the use of progesterone for any of these conditions, it is recommended to consult with a healthcare professional. This formulation is designed to provide a controlled and prolonged release of progesterone, offering a more convenient and effective treatment option for patients.